Browsing by Subject "Y10S 435/811"
Now showing items 1-9 of 9
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 2002-04-16)Neoplastic disease, hyperallergenicity, autoimmune disorders characterized by chronic tissue degenerative inflammation and immuno-resistant viral infections are treated by the administration of interferon at a dosage of ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1989-04-11)A biologically active interferon can be administered to an animal in conjunction with the administration of a vaccine to improve the vaccine efficiency and allow the use of a smaller vaccination dose. This procedure will ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1985-02-05)The appetite of a warm-blooded vertebrate can be regulated by administering to the vertebrate a biological active fraction of interferon in an amount effective to modulate the vertebrate's food intake or efficiency in ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1989-04-11)
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-12-08)Autoimmune disorders are treated by the administration of human interferon, particularly IFN-α or IFN-β, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-10-06)Bacterial infections are treated by the administration of alpha-interferon at a dosage of from about 0.1 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1999-03-16)Hyperallergenic conditions are treated by the administration of interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-10-20)Neoplastic diseases are treated by the administration of human interferon, particularly IFN-α, at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and ...
-
(United States. Patent and Trademark Office; Texas A&M University. Libraries, 1998-11-03)Viral infections are treated by the administration of alpha-interferon at a dosage of from about 0.01 to about 5 IU/lb./day such that the interferon is held in contact with the patient's oral and pharyngeal mucosae. The ...